Evidence map›Paper›PMID 31352487›Full record

ArticleThe Journal of infectious diseases2019

Association Between Zika Virus Microcephaly in Newborns With the rs3775291 Variant in Toll-Like Receptor 3 and rs1799964 Variant at Tumor Necrosis Factor-α Gene.

Camilla N O Santos, Danielle R Ribeiro, Juliana Cardoso Alves, Rodrigo A Cazzaniga, Lucas S Magalhães, Mércia S F de Souza, Adriana B L Fonseca, Ana J B Bispo, Roseane L S Porto, Cliomar Alves Dos Santos and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Identification of AMOTL2 as an antiviral factor that enhances the human type I interferon response against Zika virus.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Analysis of associations between theFrontiers in cellular and infection microbiology · 2023
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Camilla N O SantosMolecular Biology Laboratory and Graduate Program in Health Science, Federal University of Sergipe, Aracaju, Brazil.
Danielle R RibeiroMolecular Biology Laboratory, University Hospital, Federal University of Sergipe, Aracaju, Brazil.
Juliana Cardoso AlvesMolecular Biology Laboratory and Graduate Program in Health Science, Federal University of Sergipe, Aracaju, Brazil.
Rodrigo A CazzanigaMolecular Biology Laboratory, University Hospital, Federal University of Sergipe, Aracaju, Brazil.
Lucas S MagalhãesMolecular Biology Laboratory and Graduate Program in Health Science, Federal University of Sergipe, Aracaju, Brazil.
Mércia S F de SouzaSecretaria de Estado da Saúde de Sergipe, Aracaju, Brazil.
Adriana B L FonsecaMicrocephaly Clinic, Pediatric Division of University Hospital, Federal University of Sergipe, Aracaju, Brazil.
Ana J B BispoMicrocephaly Clinic, Pediatric Division of University Hospital, Federal University of Sergipe, Aracaju, Brazil.
Roseane L S PortoMicrocephaly Clinic, Pediatric Division of University Hospital, Federal University of Sergipe, Aracaju, Brazil.
Cliomar Alves Dos SantosCentral Public Health Laboratory of Sergipe, Aracaju, Brazil.
Ângela M da SilvaInfectious Disease Division of University Hospital, Federal University of Sergipe, Aracaju, Brazil.
Mauro M TeixeiraImmunopharmacology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Roque P de AlmeidaMolecular Biology Laboratory and Graduate Program in Health Science, Federal University of Sergipe, Aracaju, Brazil.
Amélia R de JesusMolecular Biology Laboratory and Graduate Program in Health Science, Federal University of Sergipe, Aracaju, Brazil.
Universidade Federal de Sergipe · BRSecretaria da Saúde · BRUniversidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital Zika syndrome (CZS) is a cluster of malformation, and the mechanisms that lead it are still unclear. Using hypothesis-driven candidate genes and their function in viral infections, single-nucleotide polymorphisms (SNPs) were genotyped by quantitative polymerase chain reaction in a sample population from Sergipe State, Brazil. This study shows that rs3775291 SNP at Toll-like receptor 3, which triggers type I interferon antiviral responses in mothers infected by Zika virus during pregnancy, is associated with CZS occurrence (odds ratio [OR], 2.19; 95% confidence interval [CI], 1.158-4.148). Moreover, rs1799964 SNP at tumor necrosis factor-α gene in CZS babies is associated with severe microcephaly (OR, 2.63; 95% CI, 1.13-6.21).

Indexed as

GenotypeAdolescentAdultBrazilFemaleGenotyping TechniquesHumansInfant, NewbornMaleMicrocephalyMiddle AgedPolymorphism, Single NucleotideReal-Time Polymerase Chain ReactionToll-Like Receptor 3Tumor Necrosis Factor-alphaYoung AdultTLR3 protein, humanTNF protein, humanToll-Like Receptor 3Tumor Necrosis Factor-alphacongenital Zika syndromemicrocephalypolymorphismTLR3TNFα

Identifiers

PMID31352487
OpenAlexW2966311683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.